The Ministry of Health (MoH) has formally denied claims of a nationwide shortage of antiretroviral (ARV) medications, assuring the public and persons living with HIV that life-saving treatments remain available across designated health facilities nationwide.
The Ministry’s response follows a public statement issued by the Network of Persons Living with HIV in Ghana (NAP+ Ghana), which raised alarms over reported shortages of certain ARVs at point-of-care health centers.
In an official statement released on August 11, 2026, the Ministry characterized allegations of widespread unavailability as inaccurate, emphasizing that distribution channels remain active to support continuous treatment and care.
Clarification on Port Clearance and Expiry Claims
In addition to addressing facility-level supply concerns, the Ministry dismissed reports suggesting that consignments of ARVs had expired while awaiting clearance at the country's ports.
"The Ministry wishes to clarify that it is incorrect to suggest that antiretroviral medicines have expired at the port," the statement read, noting that the Ministry continues to collaborate with relevant port and customs authorities to ensure timely clearance and delivery of medical commodities.
Routine Restocking and Stakeholder Engagement
The Ministry explained that current replenishment efforts at central and regional Medical Stores form part of routine procurement procedures aimed at meeting state supply obligations and preventing distribution lags.
To address ongoing concerns, health officials have held engagements with leadership from NAP+ Ghana to reassure the advocacy group of the government's commitment to maintaining an uninterrupted supply chain.
While the Ministry did not publish specific inventory figures or facility-by-facility stock metrics in its statement, it reiterated its commitment to working closely with healthcare providers and patient organizations to resolve localized distribution bottlenecks promptly.
